Transphorm (OTCMKTS:TGAN – Get Rating) and Arteris (NASDAQ:AIP – Get Rating) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.
Analyst Recommendations This is a summary of recent recommendations and price targets for Transphorm and Arteris, as provided by MarketBeat.com.
Sell Ratings
Hold Ratings
Buy Ratings
Strong Buy Ratings
Rating Score
Transphorm
0
1
1
0
2.
